Tag: FDA cleared AI eye exams

  • Home
  • FDA cleared AI eye exams
Reverse Diabetic Retinopathy Now A doctor peers through a magnifying glass at a human eye anatomy model, carefully explaining how diabetic retinopathy develops. From the clinician’s perspective, the condition is not isolated—it is part of a spectrum of eye diseases that threaten sight, including refractive errors, age-related macular degeneration (AMD), cataracts, glaucoma, amblyopia, strabismus, and, importantly, diabetic retinopathy (DR). Each disorder damages vision differently, yet DR is uniquely tied to blood sugar, blood pressure, and cholesterol control.

Reverse Diabetic Retinopathy Now

Reverse Diabetic Retinopathy Now—because the threat is widespread, yet proven solutions already exist, the time to act is now. In 2021, more than 9.6 million Americans lived with diabetic retinopathy (DR); nearly 1.84 million faced vision-threatening disease. Globally, one in three people with diabetes will develop

Read More
↑